| 前收盘价格 | 176.90 |
| 收盘价格 | 177.25 |
| 成交量 | 297,482 |
| 平均成交量 (3个月) | 497,951 |
| 市值 | 10,633,670,656 |
| 价格/销量 (P/S) | 24.50 |
| 52周波幅 | |
| 利润日期 | 1 Sep 2025 - 5 Sep 2025 |
| 营业毛利率 | -92.67% |
| 营业利益率 (TTM) | -103.23% |
| 稀释每股收益 (EPS TTM) | -6.66 |
| 季度收入增长率 (YOY) | 5.30% |
| 流动比率 (MRQ) | 1.04 |
| 营业现金流 (OCF TTM) | -218.93 M |
| 杠杆自由现金流 (LFCF TTM) | -133.44 M |
| 资产报酬率 (ROA TTM) | -22.39% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Ascendis Pharma A/S | 看涨 | 看涨 |
AIStockmoo 评分
1.6
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.63 |
|
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 0.78% |
| 机构持股比例 | 113.56% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Westfield Capital Management Co Lp | 31 Mar 2025 | 5,479,259 |
| Avoro Capital Advisors Llc | 31 Mar 2025 | 5,218,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 280.00 (Evercore ISI Group, 59.29%) | 购买 |
| 中 | 220.00 (25.16%) | |
| 低 | 200.00 (Cantor Fitzgerald, 13.78%) | 购买 |
| 平均值 | 229.63 (30.64%) | |
| 总计 | 8 购买 | |
| 平均价格@调整类型 | 169.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Oppenheimer | 13 Jun 2025 | 224.00 (27.43%) | 购买 | 170.80 |
| B of A Securities | 09 Jun 2025 | 216.00 (22.88%) | 购买 | 173.15 |
| 03 Jun 2025 | 201.00 (14.35%) | 购买 | 174.40 | |
| Cantor Fitzgerald | 12 May 2025 | 200.00 (13.78%) | 购买 | 154.43 |
| Morgan Stanley | 05 May 2025 | 250.00 (42.22%) | 购买 | 170.74 |
| Evercore ISI Group | 02 May 2025 | 280.00 (59.29%) | 购买 | 172.06 |
| JP Morgan | 02 May 2025 | 245.00 (39.38%) | 购买 | 172.06 |
| RBC Capital | 02 May 2025 | 210.00 (19.47%) | 购买 | 172.06 |
| 16 Apr 2025 | 205.00 (16.62%) | 购买 | 158.15 | |
| Wedbush | 02 May 2025 | 212.00 (20.61%) | 购买 | 172.06 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合